By: Carol Fabian, MD Date. 12/07/2023 In an interview, Carol Fabian, MD, an expert in breast…

By. Terry Mamounas Date: 12/07/2023In a collaborative study between NVP and RT, led by oncologist…

By. Ruth O’Regan MD Date: 12/07/2023In an interview, Ruth O’Regan MD addresses questions related to the…

Zandra Klippel, MD, Global Product Head, Sanofi – Phase 3 IsKia trial of Sarclisa® (isatuximab)…

Rabi Hanna, MD, from the Department of Pediatric Hematology Oncology and BMT at Cleveland Clinic…

By: Joyti Bajpai, MD Date: 12/07/2023 In a forthcoming interview, Jyoti Bajpai, MD, a renowned…

Under the lights of ASH 2023, the microphone poised to capture insights, Dr. Lorenzo Falchi,…

By. Robert Rifkin, MDDate: 12/13/2023 Robert Rifkin, MD, a medical oncologist and hematologist at SCRI…

In an interview, Andrew Evens, DO, an expert in hematology and oncology, will discuss a…

In an ongoing Phase 1/2 study, Constantine Tam, MD, a researcher and Professor of Haematology,…